Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Dr ...

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

Hoke County Sheriff’s Office said a child is dead and two people are facing multiple charges. On Monday, Hoke County Sheriff’s deputies said an unresponsive child was brought to a local hospital on ...

Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

Bimagrumab was shown to result in less total weight loss but better body composition. The fact that medication alone can cause fat loss and muscle gain at the same time was a "major breakthrough," ...

The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...